세계 측방 유동 면역 측정법(LFIA)에 근거한 신속 검사 시장 : 2033년까지의 기회와 전략

Lateral Flow Immunoassay (LFIA) Based Rapid Test Global Market Opportunities And Strategies To 2033

US $ 5,000 ￦ 7,113,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 7,500 ￦ 10,669,000

PDF (Site License)

PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 10,000 ￦ 14,226,000

PDF (Enterprise License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

세계 측방 유동 면역측정법(LFIA)을 기반으로 한 신속 검사 시장은 2018년 68억 8,441만 달러로 평가되었으며, 2023년까지 5.00% 이상의 CAGR(복합 연간 성장률)로 성장했습니다.

감염증의 높은 유병률

감염의 큰 유행은 실적 기간에 LFIA 기반 신속 검사 시장의 성장을 견인했습니다. 인플루엔자, COVID-19, 다양한 바이러스 및 박테리아 감염과 같은 질병의 세계에서 발생이 증가하고 신속하고 정확한 결과를 제공할 수 있는 신속 진단 솔루션에 대한 수요가 증가했습니다. LFIA 검사는 사용 편의성과 전문 장비의 최소한의 필요성으로 알려져 있으며 적시에 질병을 감지하고 관리할 수 있는 건강 관리 환경에서 매우 중요했습니다. 예를 들어 스위스에 본부를 두고 있는 국제 비정부기구인 세계경제포럼에 따르면 2023년에는 인플루엔자와 RS바이러스(RSV) 등의 감염이 유행 이후 증가하고 있습니다. 미국에서는 2023년 2월 시점에서 인플루엔자에 의한 추정 이환 환자수는 2,400만명, 입원자수는 26만명, 사망자수는 1만6,000명으로 되어 있습니다. 게다가 세계 최대의 생물의학 도서관인 국립의학 도서관에 따르면 2022년 네덜란드에서는 0-5세의 침습성 화농렌사구균(iGAS) 감염 보고수가 COVID-19 팬데믹 이전에 비해 7배로 증가했습니다. 그러므로 전염병의 높은 유행은 LFIA에 기초한 신속한 검사 시장의 성장을 견인했습니다.

목차

제1장 주요 요약

• 측방유동 면역 측정법(LFIA)에 기초한 신속 검사-시장의 매력과 거시 경제 상황

제2장 목차

제3장 표 일람

제4장 그림 일람

제5장 보고서 구성

제6장 시장 특징

• 일반적인 시장의 정의
• 개요
• 측방유동 면역 측정법(LFIA)에 근거한 신속 검사 시장 정의와 세분화
• 시장 세분화 : 기술별
  • 경쟁 분석
  • 샌드위치 분석
  • 멀티플렉스 검출 분석
• 시장 세분화 : 용도별
  • 감염증
  • 임신과 불임
  • 독물학
  • 심장 마커와 콜레스테롤 검사
  • 기타 용도
• 시장 세분화 : 최종 사용자별
  • 병원 및 클리닉
  • 진단 실험실
  • 홈케어
  • 기타 최종 사용자

제7장 주요 시장 동향

• 위기적인 건강 긴급 사태의 신속한 관리를 위한 휴대용 POC(Point of Care) 진단에의 주력
• 보다 긴 보존 기간을 가지는 LFIA 신속 검사를 도입하기 위한 진전

제8장 측방유동 면역측정법(LFIA)에 근거한 신속 검사 시장 - 거시경제 시나리오

• COVID-19의 영향: 측방유동 면역 측정법(LFIA)에 근거한 신속 검사 시장
• 우크라이나 전쟁의 영향: 측방유동 면역 측정법(LFIA)에 근거한 신속 검사 시장
• 고인플레이션의 영향: 측방유동 면역 측정법(LFIA)에 근거한 신속 검사 시장

제9장 세계 시장 규모와 성장

• 시장 규모
• 시장 성장 실적, 2018-2023년
  • 시장 성장 촉진요인, 2018-2023년
  • 시장 성장 억제요인, 2018-2023년
• 시장 성장 예측, 2023-2028년, 2033년
  • 시장 성장 촉진요인, 2023-2028년
  • 시장 성장 억제요인, 2023-2028년

제10장 세계의 측방유동 면역 측정법(LFIA)에 근거한 신속 검사 시장 : 세분화

• 세계의 측방유동 면역 측정법(LFIA)에 근거한 신속 검사 시장 : 기술별, 분석과 예측, 2018-2023년, 2028년, 2033년
• 세계의 측방유동 면역 측정법(LFIA)에 근거한 신속 검사 시장 : 용도별, 분석과 예측, 2018-2023년, 2028년, 2033년
• 세계의 측방유동 면역 측정법(LFIA)에 근거한 신속 검사 시장 : 최종 사용자별, 분석과 예측, 2018-2023년, 2028년, 2033년

제11장 측방유동 면역 측정법(LFIA)에 근거한 신속 검사 시장 :지역·국가별 분석

• 세계의 측방유동 면역 측정법(LFIA)에 근거한 신속 검사 시장 :지역별, 분석과 예측, 2018-2023년, 2028년, 2033년
• 세계의 측방유동 면역 측정법(LFIA)에 근거한 신속 검사 시장 : 국가별, 분석과 예측, 2018-2023년, 2028년, 2033년

제12장 아시아태평양 시장

제13장 서유럽 시장

제14장 동유럽 시장

제15장 북미 시장

제16장 남미 시장

제17장 중동 시장

제18장 아프리카 시장

제19장 경쟁 구도와 기업 프로파일

• 기업 프로파일
• Abbott Laboratories
• F. Hoffman-La Roche Ltd
• Thermo Fisher Scientific Inc
• Siemens AG
• Danaher Corporation

제20장 기타 주요 기업 및 혁신 기업

• Hologic, Inc
• bioMerieux SA
• Becton, Dickinson and Company
• Merck KGaA
• Bio-Rad Laboratories, Inc
• QIAGEN NV
• EKF Diagnostics
• QuidelOrtho Corporation
• Launch Diagnostics
• JOYSBIO(Tianjin) Biotechnology Co., Ltd
• INDICAL Bioscience
• Ubio Biotechnology Systems
• Jiangsu Medomics Medical Technologies
• Atomo Diagnostics Limited
• PerkinElmer Inc

제21장 경쟁 벤치마킹

제22장 경쟁 대시보드

제23장 주요 인수합병(M&A)

• Danaher Corporation Acquired Abcam plc
• Becton, Dickinson and Company Acquired Scanwell Health
• DiaSorin Acquired Luminex Corporation For$1.8 Billion
• PerkinElmer Inc. Acquired Immunodiagnostic Systems Holdings PLC
• Hologic Inc. Acquired Mobidiag
• Thermo Fisher Scientific Acquired Mesa Biotech Inc.

제24장 기회와 전략

• 세계의 측방유동 면역 측정법(LFIA)에 근거한 신속 검사 시장 2028년: 새로운 기회를 제공하는 국가
• 세계 측방유동 면역측정법(LFIA)에 근거한 신속 검사 시장 2028년: 새로운 기회를 제공하는 부문
• 세계의 측방유동 면역 측정법(LFIA)에 근거한 신속 검사 시장 2028년: 성장 전략
  • 시장 동향에 기초한 전략
  • 경쟁 전략

제25장 측방유동 면역 측정법(LFIA)에 근거한 신속 검사 시장 : 결론과 제안

• 결론
• 권고
  • 제품
  • 장소
  • 가격
  • 프로모션
  • 사람들

제26장 부록

SHW

영문 목차

영문목차

Lateral flow immunoassay (LFIA) based rapid tests are diagnostic tools used to detect the presence or absence of specific substances in a sample, often delivering results within a short time. These tests are a critical component in medical diagnostics, leveraging antibodies to identify biomarkers related to various conditions.

The LFIA based rapid test market consists of sales of LFIA based rapid test equipment used to run LFIA based rapid test and related services. These are testing devices used to assess the existence of a target, such as pathogens or biomarkers, in samples of urine, blood or saliva obtained from the human body.

The global lateral flow immunoassay (LFIA) based rapid test market was valued at $6,884.41 million in 2018 which grew till 2023 at a compound annual growth rate (CAGR) of more than 5.00%.

High Prevalence Of Infectious Diseases

The high prevalence of infectious diseases drove the growth of the LFIA based rapid test market during the historic period. Increased global outbreaks of diseases such as influenza, COVID-19 and various viral and bacterial infections heightened the demand for rapid diagnostic solutions that could provide quick and accurate results. LFIA tests, known for their ease of use and minimal requirement for specialized equipment, became crucial for healthcare settings, enabling timely disease detection and management. For instance, in 2023, according to the World Economic Forum, a Switzerland-based international non-governmental organization, infections such as influenza and respiratory syncytial virus (RSV) have increased since the pandemic. In the USA, an estimated 24 million illnesses, 260,000 hospitalizations and 16,000 deaths from the influenza have occurred as of February 2023. Additionally, in 2022, according to the National Library of Medicine, the world's largest biomedical library, the Netherlands saw a sevenfold rise in the number of reportable invasive Streptococcus pyogenes (iGAS) infections among children aged 0-5, compared to the years before the COVID-19 pandemic. Therefore, the high prevalence of infectious diseases drove the growth of the LFIA based rapid test market.

Focus On Portable Point-Of-Care Diagnostics For Rapid Management Of Critical Health Emergencies

Major companies operating in the LFIA based rapid test market are focusing on portable, point-of-care diagnostics that prioritize speed, ease of use and specificity to manage critical health emergencies effectively. By advancing tests that deliver rapid results, these companies aim to support timely decision-making in emergency settings, such as stroke and cardiac events, where immediate diagnosis can significantly impact patient outcomes. For example, in February 2024, Upfront Diagnostics, a UK-based healthcare company, planned to launch LVOne test, a rapid diagnostic tool designed to identify large vessel occlusion (LVO) strokes within 15 minutes using a fingerprick blood sample. It employs two portable lateral flow assays to detect specific biomarkers, the fibrin degradation D-dimer and glial fibrillary acidic protein (GFAP) from capillary blood. These biomarkers help paramedics quickly triage stroke patients, enabling faster transport to specialized stroke centers for urgent treatment.

The global lateral flow immunoassay (LFIA) based rapid test market is fairly fragmented, with a large number of small players operating in the market. The top ten competitors in the market made up to 22.95% of the total market in 2023.

Lateral Flow Immunoassay (LFIA) Based Rapid Test Global Market Opportunities And Strategies To 2033 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global lateral flow immunoassay (LFIA) based rapid test market as it emerges from the COVID-19 shut down.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market research findings.
• Benchmark performance against key competitors.
• Utilize the relationships between key data sets for superior strategizing.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.

Where is the largest and fastest-growing market for lateral flow immunoassay (LFIA) based rapid test? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The lateral flow immunoassay (LFIA) based rapid test market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market's history and forecasts market growth by geography. It places the market within the context of the wider lateral flow immunoassay (LFIA) based rapid test market; and compares it with other markets.

The report covers the following chapters

• Introduction and Market Characteristics- Brief introduction to the segmentations covered in the market, definitions and explanations about the segment by technique, by application and by end-users.
• Key Trends- Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.
• Macro-Economic Scenario- The report provides an analysis of the impact of the COVID-19 pandemic, impact of the Russia-Ukraine war and impact of rising inflation on global and regional markets, providing strategic insights for businesses in the LFIA based rapid test.
• Global Market Size And Growth- Global historic (2018-2023) and forecast (2023-2028, 2033F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
• Regional And Country Analysis- Historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison by region and country.
• Market Segmentation- Contains the market values (2018-2023) (2023-2028, 2033F) and analysis for each segment by technique, by application and by end-users in the market. Historic (2018-2023) and forecast (2023-2028) and (2028-2033) market values and growth and market share comparison by region market.
• Regional Market Size and Growth- Regional market size (2023), historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
• Competitive Landscape- Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
• Other Major And Innovative Companies-Details on the company profiles of other major and innovative companies in the market.
• Competitive Benchmarking- Briefs on the financials comparison between major players in the market.
• Competitive Dashboard- Briefs on competitive dashboard of major players.
• Key Mergers and Acquisitions- Information on recent mergers and acquisitions in the market is covered in the report. This section gives key financial details of mergers and acquisitions which have shaped the market in recent years.
• Market Opportunities And Strategies- Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
• Conclusions And Recommendations- This section includes recommendations for LFIA based rapid test providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.
• Appendix- This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Markets Covered:

• 1) By Technique: Competitive Assay; Sandwich Assay; Multiplex Detection Assay
• 2) By Application: Infectious Disease; Pregnancy And Fertility; Toxicology; Cardiac Marker And Cholesterol Testing; Other Applications
• 3) By End-Users: Hospitals And Clinics; Diagnostic Laboratories; Home Care; Other End-Users
• Companies Mentioned: Abbott Laboratories; F. Hoffmann-La Roche AG; Thermo Fisher Scientific Inc.; Siemens AG; Danaher Corporation
• Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Canada; Brazil; France; Germany; UK; Italy; Spain; Russia.
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time-series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; lateral flow immunoassay (LFIA) based rapid test indicators comparison.
• Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1 Executive Summary

• 1.1 Lateral Flow Immunoassay (LFIA) Based Rapid Test - Market Attractiveness And Macro Economic Landscape

2 Table Of Contents

3 List Of Tables

4 List Of Figures

5 Report Structure

6 Market Characteristics

• 6.1 General Market Definition
• 6.2 Summary
• 6.3 Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Definition And Segmentations
• 6.4 Market Segmentation By Technique
  • 6.4.1 Competitive Assay
  • 6.4.2 Sandwich Assay
  • 6.4.3 Multiplex Detection Assay
• 6.5 Market Segmentation By Application
  • 6.5.1 Infectious Disease
  • 6.5.2 Pregnancy And Fertility
  • 6.5.3 Toxicology
  • 6.5.4 Cardiac Marker And Cholesterol Testing
  • 6.5.5 Other Applications
• 6.6 Market Segmentation By End-Users
  • 6.6.1 Hospitals And Clinics
  • 6.6.2 Diagnostic Laboratories
  • 6.6.3 Home Care
  • 6.6.4 Other End-Users

7 Major Market Trends

• 7.1 Focus On Portable Point-Of-Care Diagnostics For Rapid Management Of Critical Health Emergencies
• 7.2 Advancements To Introduce LFIA Rapid Tests That Have Longer Shelf Life

8 Lateral Flow Immunoassay (LFIA) Based Rapid Test Market - Macro-Economic Scenario

• 8.1 COVID-19 Impact On The Lateral Flow Immunoassay (LFIA) Based Rapid Test Market
• 8.2 Impact Of The War In Ukraine On The Lateral Flow Immunoassay (LFIA) Based Rapid Test Market
• 8.3 Impact Of High Inflation On The Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

9 Global Market Size And Growth

• 9.1 Market Size
• 9.2 Historic Market Growth, 2018 - 2023, Value ($ Million)
  • 9.2.1 Market Drivers 2018 - 2023
  • 9.2.2 Market Restraints 2018 - 2023
• 9.3 Forecast Market Growth, 2023 - 2028, 2033F Value ($ Million)
  • 9.3.1 Market Drivers 2023 - 2028
  • 9.3.2 Market Restraints 2023 - 2028

10 Global Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Segmentation

• 10.1 Global Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 10.2 Global Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 10.3 Global Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By End-Users, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

11 Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Regional and Country Analysis

• 11.1 Global Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, By Region, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 11.2 Global Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, By Country, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

12 Asia-Pacific Market

• 12.1 Summary
• 12.2 Market Overview
  • 12.2.1 Region Information
  • 12.2.2 Market Information
  • 12.2.3 Background Information
  • 12.2.4 Government Initiatives
  • 12.2.5 Regulations
  • 12.2.6 Regulatory Bodies
  • 12.2.7 Major Associations
  • 12.2.8 Taxes Levied
  • 12.2.9 Corporate Tax Structure
  • 12.2.10 Investments
  • 12.2.11 Major Companies
• 12.3 Asia-Pacific Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.4 Asia-Pacific Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.5 Asia-Pacific Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By End-Users, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.6 Asia-Pacific Lateral Flow Immunoassay (LFIA) Based Rapid Test Market: Country Analysis
• 12.7 China Market
• 12.8 Summary
• 12.9 Market Overview
  • 12.9.1 Country Information
  • 12.9.2 Market Information
  • 12.9.3 Background Information
  • 12.9.4 Government Initiatives
  • 12.9.5 Regulations
  • 12.9.6 Regulatory Bodies
  • 12.9.7 Major Associations
  • 12.9.8 Taxes Levied
  • 12.9.9 Corporate Tax Structure
  • 12.9.10 Investments
  • 12.9.11 Major Companies
• 12.10 China Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.11 China Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.12 China Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By End-Users, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.13 India Market
• 12.14 India Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.15 India Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.16 India Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By End-Users, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.17 Japan Market
• 12.18 Japan Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.19 Japan Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.20 Japan Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By End-Users, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.21 Australia Market
• 12.22 Australia Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.23 Australia Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.24 Australia Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By End-Users, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.25 Indonesia Market
• 12.26 Indonesia Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.27 Indonesia Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.28 Indonesia Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By End-Users, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.29 South Korea Market
• 12.30 South Korea Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.31 South Korea Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.32 South Korea Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By End-Users, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

13 Western Europe Market

• 13.1 Summary
• 13.2 Market Overview
  • 13.2.1 Region Information
  • 13.2.2 Market Information
  • 13.2.3 Background Information
  • 13.2.4 Government Initiatives
  • 13.2.5 Regulations
  • 13.2.6 Regulatory Bodies
  • 13.2.7 Major Associations
  • 13.2.8 Taxes Levied
  • 13.2.9 Corporate Tax Structure
  • 13.2.10 Investments
  • 13.2.11 Major Companies
• 13.3 Western Europe Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.4 Western Europe Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.5 Western Europe Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By End-Users, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.6 Western Europe Lateral Flow Immunoassay (LFIA) Based Rapid Test Market: Country Analysis
• 13.7 UK Market
• 13.8 UK Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.9 UK Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.10 UK Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By End-Users, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.11 Germany Market
• 13.12 Germany Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.13 Germany Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.14 Germany Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By End-Users, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.15 France Market
• 13.16 France Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.17 France Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.18 France Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By End-Users, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.19 Italy Market
• 13.20 Italy Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.21 Italy Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.22 Italy Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By End-Users, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.23 Spain Market
• 13.24 Spain Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.25 Spain Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.26 Spain Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By End-Users, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

14 Eastern Europe Market

• 14.1 Summary
• 14.2 Market Overview
  • 14.2.1 Region Information
  • 14.2.2 Market Information
  • 14.2.3 Background Information
  • 14.2.4 Government Initiatives
  • 14.2.5 Regulations
  • 14.2.6 Regulatory Bodies
  • 14.2.7 Major Associations
  • 14.2.8 Taxes Levied
  • 14.2.9 Corporate Tax Structure
  • 14.2.10 Major Companies
• 14.3 Eastern Europe Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 14.4 Eastern Europe Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 14.5 Eastern Europe Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By End-Users, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 14.6 Eastern Europe Lateral Flow Immunoassay (LFIA) Based Rapid Test Market: Country Analysis
• 14.7 Russia Market
• 14.8 Russia Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 14.9 Russia Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 14.10 Russia Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By End-Users, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

15 North America Market

• 15.1 Summary
• 15.2 Market Overview
  • 15.2.1 Region Information
  • 15.2.2 Market Information
  • 15.2.3 Background Information
  • 15.2.4 Government Initiatives
  • 15.2.5 Regulations
  • 15.2.6 Regulatory Bodies
  • 15.2.7 Major Associations
  • 15.2.8 Taxes Levied
  • 15.2.9 Corporate Tax Structure
  • 15.2.10 Investments
  • 15.2.11 Major Companies
• 15.3 North America Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 15.4 North America Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 15.5 North America Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By End-Users, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 15.6 North America Lateral Flow Immunoassay (LFIA) Based Rapid Test Market: Country Analysis
• 15.7 USA Market
• 15.8 Summary
• 15.9 Market Overview
  • 15.9.1 Country Information
  • 15.9.2 Market Information
  • 15.9.3 Background Information
  • 15.9.4 Government Initiatives
  • 15.9.5 Regulations
  • 15.9.6 Regulatory Bodies
  • 15.9.7 Major Associations
  • 15.9.8 Taxes Levied
  • 15.9.9 Corporate Tax Structure
  • 15.9.10 Investments
  • 15.9.11 Major Companies
• 15.11 USA Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 15.12 USA Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 15.13 USA Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By End-Users, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 15.14 Canada Market
• 15.15 Canada Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 15.16 Canada Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 15.17 Canada Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By End-Users, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

16 South America Market

• 16.1 Summary
• 16.2 Market Overview
  • 16.2.1 Region Information
  • 16.2.2 Market Information
  • 16.2.3 Background Information
  • 16.2.4 Government Initiatives
  • 16.2.5 Regulations
  • 16.2.6 Regulatory Bodies
  • 16.2.7 Major Associations
  • 16.2.8 Taxes Levied
  • 16.2.9 Corporate Tax Structure
  • 16.2.10 Major Companies
• 16.3 South America Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 16.4 South America Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 16.5 South America Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By End-Users, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 16.6 South America Lateral Flow Immunoassay (LFIA) Based Rapid Test Market: Country Analysis
• 16.7 Brazil Market
• 16.8 Brazil Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 16.9 Brazil Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 16.10 Brazil Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By End-Users, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

17 Middle East Market

• 17.1 Summary
• 17.2 Market Overview
  • 17.2.1 Region Information
  • 17.2.2 Market Information
  • 17.2.3 Background Information
  • 17.2.4 Government Initiatives
  • 17.2.5 Regulations
  • 17.2.6 Regulatory Bodies
  • 17.2.7 Major Associations
  • 17.2.8 Taxes Levied
  • 17.2.9 Corporate Tax Structure
  • 17.2.10 Investments
  • 17.2.11 Major Companies
• 17.3 Middle East Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 17.4 Middle East Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 17.5 Middle East Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By End-Users, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

18 Africa Market

• 18.1 Summary
• 18.2 Market Overview
  • 18.2.1 Region Information
  • 18.2.2 Market Information
  • 18.2.3 Background Information
  • 18.2.4 Government Initiatives
  • 18.2.5 Regulations
  • 18.2.6 Regulatory Bodies
  • 18.2.7 Major Associations
  • 18.2.8 Taxes Levied
  • 18.2.9 Corporate Tax Structure
  • 18.2.10 Major Companies
• 18.3 Africa Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 18.4 Africa Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 18.5 Africa Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By End-Users, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

19 Competitive Landscape And Company Profiles

• 19.1 Company Profiles
• 19.2 Abbott Laboratories
  • 19.2.1 Company Overview
  • 19.2.2 Products And Services
  • 19.2.3 Financial Overview
• 19.3 F. Hoffman-La Roche Ltd
  • 19.3.1 Company Overview
  • 19.3.2 Products And Services
  • 19.3.3 Business Strategy
  • 19.3.4 Financial Overview
• 19.4 Thermo Fisher Scientific Inc
  • 19.4.1 Company Overview
  • 19.4.2 Products And Services
  • 19.4.3 Financial Overview
• 19.5 Siemens AG
  • 19.5.1 Company Overview
  • 19.5.2 Products And Services
  • 19.5.3 Business Strategy
  • 19.5.4 Financial Overview
• 19.6 Danaher Corporation
  • 19.6.1 Company Overview
  • 19.6.2 Products And Services
  • 19.6.3 Financial Overview

20 Other Major And Innovative Companies

• 20.1 Hologic, Inc
  • 20.1.1 Company Overview
  • 20.1.2 Products and Services
• 20.2 bioMerieux SA
  • 20.2.1 Company Overview
  • 20.2.2 Products and Services
• 20.3 Becton, Dickinson and Company
  • 20.3.1 Company Overview
  • 20.3.2 Products and Services
• 20.4 Merck KGaA
  • 20.4.1 Company Overview
  • 20.4.2 Products and Services
• 20.5 Bio-Rad Laboratories, Inc
  • 20.5.1 Company Overview
  • 20.5.2 Products and Services
• 20.6 QIAGEN N.V.
  • 20.6.1 Company Overview
  • 20.6.2 Products and Services
• 20.7 EKF Diagnostics
  • 20.7.1 Company Overview
  • 20.7.2 Products and Services
• 20.8 QuidelOrtho Corporation
  • 20.8.1 Company Overview
  • 20.8.2 Products and Services
• 20.9 Launch Diagnostics
  • 20.9.1 Company Overview
  • 20.9.2 Products and Services
• 20.10 JOYSBIO (Tianjin) Biotechnology Co., Ltd
  • 20.10.1 Company Overview
  • 20.10.2 Products and Services
• 20.11 INDICAL Bioscience
  • 20.11.1 Company Overview
  • 20.11.2 Products and Services
• 20.12 Ubio Biotechnology Systems
  • 20.12.1 Company Overview
  • 20.12.2 Products and Services
• 20.13 Jiangsu Medomics Medical Technologies
  • 20.13.1 Company Overview
  • 20.13.2 Products and Services
• 20.14 Atomo Diagnostics Limited
  • 20.14.1 Company Overview
  • 20.14.2 Products and Services
• 20.15 PerkinElmer Inc
  • 20.15.1 Company Overview
  • 20.15.2 Products and Services

21 Competitive Benchmarking

22 Competitive Dashboard

23 Key Mergers And Acquisitions

• 23.1 Danaher Corporation Acquired Abcam plc
• 23.2 Becton, Dickinson and Company Acquired Scanwell Health
• 23.3 DiaSorin Acquired Luminex Corporation For $1.8 Billion
• 23.4 PerkinElmer Inc. Acquired Immunodiagnostic Systems Holdings PLC
• 23.5 Hologic Inc. Acquired Mobidiag
• 23.6 Thermo Fisher Scientific Acquired Mesa Biotech Inc.

24 Opportunities And Strategies

• 24.1 Global Lateral Flow Immunoassay (LFIA) Based Rapid Test Market In 2028 - Countries Offering Most New Opportunities
• 24.2 Global Lateral Flow Immunoassay (LFIA) Based Rapid Test Market In 2028 - Segments Offering Most New Opportunities
• 24.3 Global Lateral Flow Immunoassay (LFIA) Based Rapid Test Market In 2028 - Growth Strategies
  • 24.3.1 Market Trend Based Strategies
  • 24.3.2 Competitor Strategies

25 Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Conclusions And Recommendations

• 25.1 Conclusions
• 25.2 Recommendations
  • 25.2.1 Product
  • 25.2.2 Place
  • 25.2.3 Price
  • 25.2.4 Promotion
  • 25.2.5 People

26 Appendix

• 26.1 Geographies Covered
• 26.2 Market Data Sources
• 26.3 Research Methodology
• 26.4 Currencies
• 26.5 The Business Research Company
• 26.6 Copyright and Disclaimer